TD Cowen analyst Joshua Jennings reiterates DexCom (NASDAQ:DXCM) with a Buy and maintains $95 price target.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
The AI economy, Apple's iPhone Duo issues, and Meta partners with Nvidia
Yahoo53 Minutes Ago
Can Apple charge $38.99 for new Siri AI?
Yahoo1 Hour Ago
Pfizer (PFE) Scores Phase 3 Cancer Win As FDA Broadens Another Oncology Approval
Yahoo1 Hour Ago
The Sherwin-Williams Company Q3 2026 Earnings Call Summary
Yahoo1 Hour Ago
Which Real Estate ETF Is the Better Buy: State Street’s XLRE or Northern Trust’s Global GQRE?
Yahoo2 Hours Ago
Alpaca · SIPUpdated 14:18 NY15 Minutes Delayed
